Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
U ndergraduate writing programs introduce college students to the rhetorical and argumentative structures they will be expected to master during their four years on campus and beyond. Learning the ...
Veronica Beagle is the managing editor for Education at Forbes Advisor. She completed her master’s in English at the University of Hawai‘i at Mānoa. Before coming to Forbes Advisor she worked on ...
Starting in autumn quarter 2025, the University will begin a multi-year restructuring of the undergraduate writing program, which had previously run concurrently with the humanities Core sequence.
Applications for the Fall 2025 Writing Mentor Program are now available. Click here for the application. Deadline to apply is Tuesday, September 16, 2025 at 12pm. Have you ever wanted a personal ...
The University of Arizona is terminating its Writing Skills Improvement Program, a move that closes the door for students to receive instruction from specialists with professional degrees in writing, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback